Search research articles
Contact Us
Filters
Showing results (61-70 of 82) with videos related to
Page
of 9
Sort By:
Plos One
|
February 24, 2012
Protein kinase C iota regulates pancreatic acinar-to-ductal metaplasia
Michele L Scotti, Kristin E Smith, Amanda M Butler, et al.
Cancer Cell
|
August 6, 2019
Protein Kinase Cι and Wnt/β-Catenin Signaling: Alternative Pathways to Kras/Trp53-Driven Lung Adenocarcinoma
Ning Yin, Yi Liu, Andras Khoor, et al.
Cancer Cell
|
December 11, 2019
Protein Kinase Cι and Wnt/β-Catenin Signaling: Alternative Pathways to Kras/Trp53-Driven Lung Adenocarcinoma
Ning Yin, Yi Liu, Andras Khoor, et al.
Metabolism: Clinical and Experimental
|
January 10, 2012
Correction of metabolic abnormalities in a rodent model of obesity, metabolic syndrome, and type 2 diabetes mellitus by inhibitors of hepatic protein kinase C-ι
Mini P Sajan, Sonali Nimal, Stephen Mastorides, et al.
American Journal of Clinical Oncology
|
October 20, 2025
A Phase 2 Trial of Protein Kinase C Iota Inhibition With the Combination of Auranofin and Sirolimus in Patients With Recurrent Ovarian Cancer
Aminah Jatoi, Nathan R Foster, Andrea Wahner Hendrickson, et al.
Cell Reports
|
January 23, 2020
Chromosome 3q26 Gain Is an Early Event Driving Coordinated Overexpression of the PRKCI, SOX2, and ECT2 Oncogenes in Lung Squamous Cell Carcinoma
Yi Liu, Ning Yin, Xue Wang, et al.
The Journal of Cell Biology
|
March 17, 2004
Protein kinase Ciota is required for Ras transformation and colon carcinogenesis in vivo
Nicole R Murray, Lee Jamieson, Wangsheng Yu, et al.
The Journal of Cell Biology
|
June 12, 2002
Protein kinase C betaII and TGFbetaRII in omega-3 fatty acid-mediated inhibition of colon carcinogenesis
Nicole R Murray, Capella Weems, Lu Chen, et al.
The Journal of Biological Chemistry
|
December 14, 2002
Role of cyclooxygenase 2 in protein kinase C beta II-mediated colon carcinogenesis
Wangsheng Yu, Nicole R Murray, Capella Weems, et al.
Oncology
|
December 16, 2014
A mixed-methods feasibility trial of protein kinase C iota inhibition with auranofin in asymptomatic ovarian cancer patients
Aminah Jatoi, Carmen Radecki Breitkopf, Nathan R Foster, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 82) with videos related to
Sort By:
Page
of 9
Plos One
|
February 24, 2012
Protein kinase C iota regulates pancreatic acinar-to-ductal metaplasia
Michele L Scotti, Kristin E Smith, Amanda M Butler, et al.
Cancer Cell
|
August 6, 2019
Protein Kinase Cι and Wnt/β-Catenin Signaling: Alternative Pathways to Kras/Trp53-Driven Lung Adenocarcinoma
Ning Yin, Yi Liu, Andras Khoor, et al.
Cancer Cell
|
December 11, 2019
Protein Kinase Cι and Wnt/β-Catenin Signaling: Alternative Pathways to Kras/Trp53-Driven Lung Adenocarcinoma
Ning Yin, Yi Liu, Andras Khoor, et al.
Metabolism: Clinical and Experimental
|
January 10, 2012
Correction of metabolic abnormalities in a rodent model of obesity, metabolic syndrome, and type 2 diabetes mellitus by inhibitors of hepatic protein kinase C-ι
Mini P Sajan, Sonali Nimal, Stephen Mastorides, et al.
American Journal of Clinical Oncology
|
October 20, 2025
A Phase 2 Trial of Protein Kinase C Iota Inhibition With the Combination of Auranofin and Sirolimus in Patients With Recurrent Ovarian Cancer
Aminah Jatoi, Nathan R Foster, Andrea Wahner Hendrickson, et al.
Cell Reports
|
January 23, 2020
Chromosome 3q26 Gain Is an Early Event Driving Coordinated Overexpression of the PRKCI, SOX2, and ECT2 Oncogenes in Lung Squamous Cell Carcinoma
Yi Liu, Ning Yin, Xue Wang, et al.
The Journal of Cell Biology
|
March 17, 2004
Protein kinase Ciota is required for Ras transformation and colon carcinogenesis in vivo
Nicole R Murray, Lee Jamieson, Wangsheng Yu, et al.
The Journal of Cell Biology
|
June 12, 2002
Protein kinase C betaII and TGFbetaRII in omega-3 fatty acid-mediated inhibition of colon carcinogenesis
Nicole R Murray, Capella Weems, Lu Chen, et al.
The Journal of Biological Chemistry
|
December 14, 2002
Role of cyclooxygenase 2 in protein kinase C beta II-mediated colon carcinogenesis
Wangsheng Yu, Nicole R Murray, Capella Weems, et al.
Oncology
|
December 16, 2014
A mixed-methods feasibility trial of protein kinase C iota inhibition with auranofin in asymptomatic ovarian cancer patients
Aminah Jatoi, Carmen Radecki Breitkopf, Nathan R Foster, et al.
Page
of 9